越桔酒渣花色素及其生物学活性研究
详细信息    本馆镜像全文|  推荐本文 |  |   获取CNKI官网全文
摘要
越桔(Vaccinium uliginosum L.)酒渣是果实酿酒初级利用后的工业废弃物,花色素是其中所含的生物活性成分之一。为探寻越桔酒渣综合利用的技术途径,实现资源深度开发,本文就越桔酒渣花色素的提取精制工艺、主要化学成分类型、抗氧化、抑制肿瘤及调节血压等方面展开研究。
     采用单因素比较和正交试验法,首先探讨花色素提取和精制的技术条件,越桔酒渣花色素提取的最佳条件为:室温条件,80%pH3.0乙醇作浸提剂,料液比1:40,提取2.5h;用HPD100大孔树脂对色素进行精制,树脂柱径高比1:10,花色素浓度0.5g/L,流速1mL/min为最佳吸附条件,色素吸附量可达到0.0987g/mL湿树脂;60%pH3.0乙醇作洗脱液,流速1mL/min,4.5倍柱体积的洗脱液条件下解析效果最佳,色素回收率达到95.48%;制取的花色素呈紫红色,色价为91.5,得率为3.00%。
     研究制取花色素理化性质表明,越桔酒渣花色素(Pigment from WildVaccinium uliginosum L.Wine Pomace,简称PVP)属花色苷类,为水溶性色素。采用高效液相法对PVP进行分析,初步确定PVP中含有槲皮素、杨梅素及异鼠李素等黄酮类化合物。
     体外抗氧化活性试验表明,PVP表现出很强的清除DPPH·和·O_2~-活性,IC_(50)分别为10.69μg/mL和224.01μg/mL。同时,一定浓度的PVP可以抑制黄嘌呤氧化酶(xanthine oxidase,简称XO)的活性。10μg/mL的PVP能够抑制600μMH_2O_2对牛主动脉内皮细胞(bovine aortic endothelial cells,简称BAECs)的过氧损伤,清除细胞内活性氧(Reactive Oxygen Species,简称ROS),改善内皮功能障碍。
     采用MTT法观察PVP体外对人鼻咽癌(CNE)、肾癌(786-O)及结肠癌(HCT-8)细胞增殖的抑制作用,结果显示:PVP抑制人鼻咽癌细胞(CNE)增殖的IC_(50)为80.30 mg/L;对肾癌细胞(786-O)具有一定的抑制作用,300 mg/L为抑制细胞增殖的最高临界点,抑制率为68.43%;对人结肠癌细胞(HCT-8)增殖抑制的IC_(50)为250.29mg/L。据报道肠道具有酶解花色苷成花色素的作用,肠道对花色素苷的吸收具有重要意义,因此对人结肠癌细胞(HCT-8)展开进一步的研究。研究采用Wright染色法、吖啶橙染色法观察PVP作用HCT-8后的细胞形态,结果发现HCT-8经PVP作用后,出现凋亡特征,细胞变小皱缩,核凝固,细胞膜破裂等;流式细胞仪观察PVP对细胞周期的影响,表明PVP下调G_0/G_1期细胞比例,减少HCT-8细胞有丝分裂和细胞分化,从而促进细胞凋亡。
     采用自发性高血压大鼠(spontaneously hypertensive rats,简称SHR)为模型,每日定时灌胃一次PVP,连续4周,结果发现,高剂量PVP(150mg/kg·dbw)SHR大鼠饮水量显著增高,体重增长缓慢,血压显著降低,血清甘油三酯(TG)含量显著减少,但PVP对血清葡萄糖(Glu),总胆固醇(TC),高密度脂蛋白总胆固醇(HDL-C)和总抗氧化能力(T-AOC)无显著影响,提示PVP除具一定的降压作用外还具有调节血脂的潜在作用。
     蓝莓软胶囊(bluebeery soft capsulem,简称BSC)是以越桔酒渣提取物为主要成分的产品,搞清楚其生物学活性对于指导产业化生产具有重要意义。本文继续将SHR大鼠诱导成高血压高甘油三酯合并的动物模型,以研究BSC对血压和血脂的调节作用。研究参考文献方法,利用高脂高糖饲料喂养SHR大鼠,同时每日定时灌胃BSC一次,观察BSC对高甘油三酯SHR大鼠的影响。结果表明饲喂高脂高糖10周后,SHR大鼠血清TG水平显著升高,同时每日灌胃BSC不能预防SHR大鼠TG的升高,但低剂量的BSC(250mg/kg bw)可以使SHR大鼠血清TG的增长缓慢。BSC可以显著降低高甘油三酯SHR大鼠的血压,降幅接近10%,起到改善血压的作用;高剂量BSC(500g/kg bw)可以显著降低高甘油三酯SHR大鼠血清TC及游离脂肪酸(FFA)含量,提高血清HDL-C和肝脏肝酯酶(HL)含量;高低剂量的BSC都可以极显著减低肝脏丙二醛(MDA)含量,起到抗氧化的作用。综上所述,越桔酒渣提取物制成品具有一定的调节SHR大鼠血压和血脂功效。
Wild Vaccinium uliginosum L. wine pomaces were rubbishes of primary manufacture in the industry, which contained pigments, a bioactivity ingredient. The depth exploiture for resource of Vaccinium uliginosum L., this paper studied the extracting and redining technology of the pigment, primary component pigment type, antioxidant, anti-carcinogenic and regulating blood pressure.
     We firstly focused the extracting and refining technology of the pigment of wild Vaccinium uliginosum L. wine pomaces(PVP).The results showed that the best extracting conditions was 80% ethanol used 40 fold volume of wine pomances, pH 3.0, 2.5 hours under room temperature;the HPD-100 macroporous resin was used to refine the pigment;and the best adsorption conditions was 0.5g/L pigment solution, 1 mL/min, diament vs height 1:1,and the adsorption capacity was 0.0987g/mL wet resin; the 60% ethanol was used eluting solvent, pH3.0, 1 mL/min and 3 fold eluting solvent volume were the best desorption conditions, the pigment can be gotten more than 95.48% of that all. The pigment produced by this methods was purple power, its color value was 91.5 and output ratio can get 3.00%。
     Study on chemistry characteristic of the pigment showed that PVP was a type of anthocyanins, and had good water solubility. There were myricetin, quercetin and isorhamnetin in PVP by HPLC.
     The results of antioxidant activity in vitro experiment demonstrated that PVP can scavenge DPPH and O_2~- strongly with IC_(50) of 10.69μg/mL and 224.01μg/mL. Meanwhile, in the experiment of xanthine oxidase (XO), PVP can inhabited the activity of XO(P<0.05).And 10μg/mL PVP can protect bovine aortic endothelial cells (BAECs) from H_2O_2 with the concentration of 600μM induced injury, decrease the contents of ROS and improve the endothelial dysfunction.
     The anti-carcinogenic effect of PVP was to be evaluated by MTT. The results showed that PVP can inhibit the growth of human nasopharyngeal carcinoma cell (CNE) with IC_(50) 80.30 mg/L, PVP can inhibit the cytotoxic of human renal carcinoma cell (786-O) and 300 mg/L was the best concentration, and human colon carcinoma cell (HCT-8) with the IC_(50) was 250.29mg/L. some studies reported that anthocyanins also were effective presumably due to their deglycosylation to cyanidin by cecal bacteria and PVP induced-apoptosis on HCT-8 was investigated further. Several methods of morphological observation were used, such as Wright staining, acidine orange staining, the results showed the morphological changes were induced by PVP with apoptosis on HCT-8. And flow cytometry was used to study the cycle of HCT-8. The results were that the G_0/G_1 phase, cell mitosis and cell differentiation were decreased, so PVP can advance the apoptosis of HCT-8.
     The blood pressure of SHR was lower than positive control (Pos) after taking the PVP for 4 weeks,the water taking was much more than Pos, the amplitude of weight was slower, (150mg/ kg·d·bw)PVP can decrease the plasmas TG of SHR, but there were no effect of Glu, TC, HDL-C and T-AOC in plasmas of SHR, which showed SHR can regulate the blood pressure and blood fats.
     The main component of bluebeery soft capsulem (BSC) was the extraction of Vaccinium uliginosum L. wine pomaces, and it's important to make the bioactivity clear. So the model of spontaneously hypertensive rats (SHR) with hyperlipemia was used to study the bioactivity of BSC. Based on former research, the SHR consumed the food of high sugar and high fat, and intragastric administration every day for 10 weeks. The results demonstrated that the levels of TG in SHR increased significantly after taking food of high sugar and high fat, and BSC can prevent the increasing of TG. But (500g/kg·bw·d ) BSC can make the increasing slowly and decrease the blood pressure, the level of plasma TC and FFA ,increase the level plasma HDL-C and HL in liver of SHR with high TG. As well, BSC can decrease the level of MDA in liver significantly, and displayed the effect of antioxidant. In all, the products of Vaccinium uliginosum L. wine pomaces can regulate the blood pressure and blood lipids of SHR.
引文
1. 王璇琳,越桔的资源,品质及药用研究概况[J].中国林副特产,1999(3):p.42-44.
    
    2. 张萍,大兴安岭野生越橘与经营对策[J].中国林副特产,2006(3):p.96-96.
    
    3. 江苏新医学院,中药大辞典[M].1977:上海科学技术出版社.2335.
    
    4. 卢艳花,欧洲越桔和笃斯越桔体外抗氧化活性比较[J].中草药,2004(6):p.674-675.
    
    5. Norton, C, Wild blueberry-rich diets affect the contractile machinery of the vascular smooth muscle in the Sprague-Dawley rat[J]. J Med Food., 2005. 8(1): p. 8-13.
    
    6. 崔克城,大兴安岭野生越桔的区划和利用现状[J].林业勘查设计,2001(2):p.64-65.
    
    7. 孙学伦,长白山区越桔发展的可行性研究[J].林业科技,2001(6):p.50-51.
    
    8. 马福龙,野生笃斯越桔人工改良及改良品种拟自然状态栽培丰产途径[J].林业勘察 设计,2003(127):p.52-53.
    
    9. 吴兴壮,越桔果实资源的开发利用现状及前景预测[J].辽宁农业科学,2003(6):p. 23-24.
    
    10. 张玉岩,以实施“天保”工程为契机搞好林区资源综合开发[J].中国林业企业,1999(3): p.18-20.
    
    11. 张华,天然林保护工程与森工企业再就业[J].中国林业企业,1999(2):p.12-13.
    
    12. 凌海波,越桔饮料加工工艺[J].保鲜与加工,200l(4):p.14-16.
    
    13. 孔书敬,越桔色素的性质研究[J].黑龙江商学院学报,2000(1):p.25-28,38.
    
    14. 潘一峰,越桔果渣中黄酮类成分抗氧化活性的研究[J].食品科学,2005(10):p. 206-210.
    
    15. 瞿伟菁,张雯,越桔果渣黄酮用于制备防治高脂血症的药物的方法[P],华东师范大 学,2005.
    
    16. 潘一峰,越桔黄酮及其生物学活性研究[D],2005华东师范大学硕士论文.
    
    17. 郭小李,越桔果渣黄酮对高尿酸血症的影响[J].营养学报,2007(2):p.199-201.
    
    18. Staessen, J.A., Essential hypertension[J]. Lancet, 2003. 361(9369): p. 1629-1641.
    
    19. 孟皓波,代谢综合征与高血压[J].内蒙古医学杂志,2007(8):p.909-912.
    
    20. 李雪芹,粟米草提取物对自发性高血压大鼠的降压作用[J].山东医药,2005(17):p. 8-9.
    
    21. 孟云辉,镇肝熄风汤对白发性高血压大鼠脑保护作用的研究[J].北京中医药大学学 报,2007(2):p.101-104.
    
    22. Williams, C.A.R.J. Grayer, Anthocyanins and other flavonoids[J]. Nat Prod Rep, 2004. 21(4): p. 539-73.
    
    23. Prior, R.L., Antioxidant capacity as influenced by total phenolic and anthocyanin content, maturity, and variety of Vaccinium species[J]. J Agric Food Chem, 1998. 46(7): p. 2686-2693.
    
    24. Viljanen, K., Inhibition of protein and lipid oxidation in liposomes by berry phenolics[J]. J Agric Food Chem, 2004. 52(24): p. 7419-24.
    
    25. Smith, M.A.L., Bioactive properties of wild blueberry fruits[J]. J Food Science, 2000. 65(2): p. 352-356.
    
    26. Cooke, D., Anthocyans from fruits and vegetables-does bright colour signal cancer chemopreventive activity?[J]. Eur J Cancer, 2005. 41(13): p. 1931-40.
    
    27. Kowalczyk, E., Anthocyanins in medicine[J]. Pol J Pharmacol, 2003. 55(5): p. 699-702.
    
    28. 胡雅馨,蓝莓果实中主要营养及花青素成分的研究[J].食品科学,2006(10):p. 600-603.
    
    29. Wang, S.Y., Antioxidant activity in lingonberries (Vaccinium vitis-idaea L.) and its inhibitory effect on activator protein-1, nuclear factor-kappaB, and mitogen-activated protein kinases activation[J]. J Agric Food Chem, 2005. 53(8): p. 3156-66.
    
    30. Schmidt, B.M., Differential effects of blueberry proanthocyanidins on androgen sensitive and insensitive human prostate cancer cell lines[J]. Cancer Letters, 2006. 231(2): p. 240-246.
    
    31. Lietti, A., Studies on Vaccinium myrtillus anthocyanosides. I. Vasoprotective and antiinflammatory activity[J]. Arzneimittelforschung, 1976. 26(5): p. 829-32.
    
    32. 柳云溪,黑果越桔的研究进展[J].国外医药:植物药分册,1998(1):p.13-17.
    
    33. 李亚东,我国越桔产业发展的思考[J].中国果树,2006(1):p.46-47.
    
    34. 邹阳,Ab-8大孔吸附树脂对蓝莓色素吸附和分离的特性研究[J].中国食品添加剂, 2007(1):p.80-82,99.
    
    35. 刘德文,大兴安岭越桔果皮中的天然宝石红色素[J].东北林业大学学报,2001(2):p. 106-108.
    
    36. 邹阳,野生蓝莓果实中花色苷色素提取工艺的研究[J].中国食品添加剂,2007.1:p. 60-62.
    
    37. 杨树春,越桔花青素的提取方法[P]2003.
    
    38. 向道丽,酶法提取越桔果渣花色苷酶解条件的研究[J].中国林副特产,2005(6):p. 1-3.
    
    39. 李春喜,生物统计学(第二版)[M].2001,北京:科学出版社.265-281.
    
    40. 范新生,医药数理统计学习辅导[M].2004,北京:科学出版社.131-156.
    
    41. 李进,大孔树脂吸附分离黑果枸杞色素的研究[J].食品科学,2005(6):p.47-51.
    
    42. 国家药典委员会,中华人民共和国药典2005年版一部[M].2005:化学工业出版社. 127-128.
    
    43. 霍琳琳,分光光度法测定桑葚总花色苷含量的研究[J].酿酒,2005(4):p.88-89.
    
    44. 马银海,叶子花红色素提取工艺的优化[J].食品科学,2003.24(1):p.78-80.
    
    45. 肖崇厚,中药化学[M].1997,上海:科学技术出版社.
    
    46. 徐任生,天然产物化学[M].1997,北京:科学出版社.17-46.
    
    47.Stintzing, F.C.R. Carle, Functional properties of anthocyanins and betalains in plants, food, and in human nutrition[J]. Trends Food Sci Technol, 2004. 15(1): p. 19-38.
    
    48.Giusti, M.M.R.E. Wrolstad, Acylated anthocyanins from edible sources and their applications in food systems[J]. Bio Eng J1, 2003. 14(3): p. 217-225.
    
    49.Canter, P.H.E. Ernst, Anthocyanosides of Vaccinium myrtillus (Bilberry) for night vision -A systematic review of placebo-controlled trials[J]. Surv Ophthalmol, 2004. 49(1): p. 38-50.
    
    50.de Gaulejac, N.S., Free radical scavenging effect of anthocyanins in red wines[J]. Food Research International, 1999. 32(5): p. 327-333.
    
    51.Youdim, K.A., Incorporation of the elderberry anthocyanins by endothelial cells increases protection against oxidative stress[J]. Free Radic Biol Med, 2000. 29(1): p. 51-60.
    
    52. 甘振威,长白山区几种野生浆果营养成分及延缓衰老作用[J].西安交通大学学报:医 学版,2004(4):p.343-345.
    
    53. Kalea, A.Z., Wild blueberry (Vaccinium angustifolium) consumption affects the composition and structure of glycosaminoglycans in Sprague-Dawley rat aorta[J]. J Nutr Biochem, 2006. 17(2): p. 109-116.
    
    54. 陶欣艺,欧洲越桔和笃斯越桔对神经细胞氧化损伤的保护作用[J].中国临床康复, 2005(33):p.50-52,i0002.
    
    55. 李进,黑果枸杞色素的抗氧化活性研究[J].中国中药杂志,2006(14):p.1179-1183.
    
    56. 汪河滨,黑果枸杞色素清除自由基活性的研究[J].食品研究与开发,2006.27(11):p. 8-10.
    
    57. 庞素秋,楮实子红色素体外抗氧化作用研究[J].中药材,2006.29(3):p.262-265.
    
    58.Owen, P.L.T. Johns, Xanthine oxidase inhibitory activity of northeastern North American plant remedies used for gout[J]. J Ethnopharmacol, 1999. 64(2): p. 149-160.
    
    59. 叶希韵,山楂总黄酮对血管内皮细胞氧化损伤的保护作用[J].中国现代应用药学杂 志,2002.19(4):p.265-268.
    
    60. 徐西振,银杏叶提取物对牛主动脉内皮细胞增殖及其机制[J].细胞生物学杂志, 2007(4):p.613-616.
    
    61.Li, J.J., Role of oxidative stress in the apoptosis of hepatocellular carcinoma induced by combination of arsenic trioxide and ascorbic acid[J]. Acta Pharmacologica Sinica, 2006. 27(8): p. 1078-1084.
    
    62.Serraino, I., Protective effects of cyanidin-3-O-glucoside from blackberry extract against peroxynitrite-induced endothelial dysfunction and vascular failure[J]. Life Sciences, 2003. 73(9): p. 1097-1114.
    
    63.Molan, A.L., Satiety in rats following blueberry extract consumption induced by appetite-suppressing mechanisms unrelated to in vitro or in vivo antioxidant capacity[J]. Food Chemistry, 2008. 107(3): p. 1039-1044.
    
    64.Zheng, W.S.Y. Wang, Oxygen radical absorbing capacity of phenolics in blueberries, cranberries, chokeberries, and lingonberries[J]. J Agric Food Chem., 2003. 51(2): p. 502-509.
    
    65.Valentovaet, K., Cytoprotective effect of a bilberry extract against oxidative damage of rat hepatocytes [J]. Food Chemistry, 2007. 101: p. 912-917.
    
    66.Duffy, K.B., A blueberry-enriched diet provides cellular protection against oxidative stress and reduces a kainate-induced learning impairment in rats[J]. Neurobiol Aging, 2007.
    
    67.Wu, X.L., Absorption and metabolism of anthocyanins in elderly women after consumption of elderberry or blueberry[J]. JNutr, 2002. 132(7): p. 1865-1871.
    
    68.Cao, GH., Anthocyanins are absorbed in glycated forms in elderly women: a pharmacokinetic study[J]. Am J Clin Nutr, 2001. 73(5): p. 920-926.
    
    69.Shimizu, S., Possible involvement of hydroxyl radical on the stimulation of tetrahydrobiopterin synthesis by hydrogen peroxide and peroxynitrite in vascular endothelial cells[J]. Int J Biochem Cell Biol, 2005. 37(4): p. 864-875.
    
    70.Matchett, M.D., Inhibition of matrix metalloproteinase activity in DU145 human prostate cancer cells by flavonoids from lowbush blueberry (Vaccinium angustifolium): possible roles for protein kinase C and mitogen-activated protein-kinase-mediated events[J]. J Nutr Biochem, 2006. 17(2): p. 117-125.
    
    71.Yi, W., Effects of phenolic compounds in blueberries and muscadine grapes on HepG2 cell viability and apoptosis [J]. Food Res, 2006. 39(5): p. 628-638.
    
    72.Kang, S.Y., Tart cherry anthocyanins inhibit tumor development in Apc(Min) mice and reduce proliferation of human colon cancer cells[J]. Cancer Letters, 2003. 194(1): p. 13-19.
    
    73.Lala, G., Anthocyanin-rich extracts inhibit multiple biomarkers of colon cancer in rats[J]. Nutr Cancer, 2006. 54(1): p. 84-93.
    
    74.Seeram, N.P., Blackberry, black raspberry, blueberry, cranberry, red raspberry, and strawberry extracts inhibit growth and stimulate apoptosis of human cancer cells in vitro[J]. J Agric Food Chem, 2006. 54(25): p. 9329-9339.
    
    75. 杨煌建,蒺藜皂苷抑制肾癌细胞增殖的研究[D],2006华东师范大学硕士论文.
    
    76. 王淳凯,五种植物挥发油生物活性及组分表征[D],2006华东师范大学硕士论文.
    
    77.Nicoletti I, A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry[J]. J Immunol Methods, 1991. 139(2): p. 271-279.
    
    78.Liu, R.H., Health benefits of fruit and vegetables are from additive and synergistic combinations of phytochemicals[J]. Am J Clin Nutr, 2003. 78(3): p. 517S-520S.
    
    79.Duthie, S.J., The effects of cranberry juice consumption on antioxidant status and??biomarkers relating to heart disease and cancer in healthy human volunteers [J]. Eur J Nutr, 2006. 45(2): p. 113-122.
    
    80.Johnson, I.T., New approaches to the role of diet in the prevention of cancers of the alimentary tract[J]. Mutat Res, 2004. 551(1-2): p. 9-28.
    
    81.W. Robert Bruce, A.G.a.A.M., Possible Mechanisms Relating Diet and Risk of Colon Cancer[J]. Cancer Epidemiol Biomarkers Prev, 2000. 9(12): p. 1271-1279.
    
    82.Lazze, M.C., Anthocyanins protect against DNA damage induced by tert-butyl-hydroperoxide in rat smooth muscle and hepatoma cells[J]. Mutat Res., 2003. 535(1): p. 103-115.
    
    83.Hagiwara A, Y.H., Prevention by natural food anthocyanins, purple sweet potato color and red cabbage color, of 2-amino-l-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP)-associated colorectal carcinogenesis in rats initiated with 1,2-dimethylhydrazine.[J]. J Toxicol Sci., 2003. 27(1): p. 57-68.
    
    84.Hou, D.X., Anthocyanidins inhibit activator protein 1 activity and cell transformation: structure-activity relationship and molecular mechanisms [J]. Carcinogenesis, 2004. 25(1): p. 29-36.
    
    85.Z Dong, M.B., RG Watts, LM Matrisian and NH Colburn Blocking of Tumor Promoter-Induced AP-1 Activity Inhibits Induced Transformation in JB6 Mouse Epidermal Cells[J]. Proceeding of the National Academy of Sciences of the United State of American, 1994. 91(2): p. 609-613.
    
    86.Wang, H.B., Antioxidant and antiinflammatory activities of anthocyanins and their aglycon, cyanidin, from tart cherries (vol 62, pg 296, 1999)[J]. J Nat Prod, 1999. 62(5): p. 802-802.
    
    87.Seeram, N.P., Cyclooxygenase inhibitory and antioxidant cyanidin glycosides in cherries and berries[J]. Phytomedicine, 2001. 8(5): p. 362-369.
    
    88.Chinery, R., Antioxidants reduce cyclooxygenase-2 expression, prostaglandin production, and proliferation in colorectal cancer cells[J]. Cancer Research, 1998. 58(11): p. 2323-2327.
    
    89.Suh, N., Discovery of natural product chemopreventive agents utilizing HL-60 cell differentiation as a model[J]. Anticancer Res, 1995. 15(2): p. 233-9.
    
    90. 潘一峰,高效液相色谱法分析测定越桔果渣中的黄酮甙元[J].天然产物研究与开发, 2005(5):p.642-644,641.
    
    91. 孟凡丽,红豆越橘果实中3-半乳糖-矢车菊色素的提取、分离及结构鉴定[J].吉林农 业大学学报,2004(5):p.529-531.
    
    92. 李亚东,不同基因型越橘果实中4种花色苷含量的研究[J].园艺学报,2004(3):p. 367-368.
    
    93.Thom, T., Heart disease and stroke statistics - 2006 update: A report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee (vol 113, pg e85, 2006)[J]. Circulation, 2006. 113(14): p. E696-E696.
    
    94.Collins, R., Blood pressure, stroke, and coronary heart disease. Part 2, Short-term reductions in blood pressure: overview of randomised drug trials in their epidemiological context[J]. Lancet, 1990. 335(8693): p. 827-38.
    
    95.Sokol, S.I., Blood pressure reduction in the primary and secondary prevention of stroke[J]. Curr Vasc Pharmacol, 2006. 4(2): p. 155-60.
    
    96.Detre, Z., Studies on vascular permeability in hypertension: action of anthocyanosides[J]. Clin Physiol Biochem, 1986. 4(2): p. 143-9.
    
    97.Reed, J., Cranberry flavonoids, atherosclerosis and cardiovascular health[J]. Crit Rev Food Sci Nutr., 2002. 42(3): p. 301-316.98.Neto, C.C., Cranberry and blueberry: Evidence for protective effects against cancer and??vascular diseases[J]. Mol Nutr Food Res, 2007. 51(6): p. 652-664.
    
    99.Bertuglia, S., Effect of Vaccinium myrtillus anthocyanosides on ischaemia reperfusion injury in hamster cheek pouch microcirculation[J]. Pharmacol Res, 1995. 31(3-4): p. 183-7.
    
    100.Pravenec, M.V. Kren, Genetic analysis of complex cardiovascular traits in the spontaneously hypertensive rat[J]. Exp Physiol, 2005. 90(3): p. 273-276.
    
    101.Tai, M.H., Increased superoxide anion in rostral ventrolateral medulla contributes to hypertension in spontaneously hypertensive rats via interactions with nitric oxide[J]. Free Radic Biol Med, 2005. 38(4): p. 450-462.
    
    102. 牛伟,蒺藜皂苷对代谢综合征的影响及有效成分分析[D],2005华东师范大学硕士论 文.
    
    103. Lau, F.C., Inhibitory effects of blueberry extract on the production of inflammatory mediators in lipopolysaccharide-activated BV2 microglia[J]. J Neur Res, 2007. 85(5): p. 1010-1017.
    
    104. 李丹,越桔食品资源的开发与利用[J].食品与发酵工业,2000(4):p.76-81.
    
    105. 李亚东,蓝莓果实的成分及保健机能[J].中国食物与营养,2002(1):p.27-28.
    
    106. 张华,越桔红色素提取工艺的研究[J].辽宁农业科学,1998(2):p.8-12.
    
    107. 王振宇,CO2超临界——超声波联用技术萃取花色苷工艺[J].东北林业大学学报, 2005(1):p.83-84.
    
    108. 杨桂霞,RP-HPLC测定栽培种越桔果中花色素的含量[J].药物分析杂志,2005. 25(10):p.1222-1224.
    
    109.Du, Q.Z., Isolation of two anthocyanin sambubiosides from bilberry (Vaccinium myrtillus)by high-speed counter-current chromatography[J]. J Chro A, 2004. 1045(1-2): p. 59-63.
    
    110.Ichiyanagi, T., Simultaneous comparison of relative reactivities of twelve major anthocyanins in bilberry towards reactive nitrogen species[J]. Chem Pharm Bull (Tokyo), 2004. 52(11): p. 1312-5.
    
    111.Cabrita L., Anthocyanin trisaccharides in blue berries of Vaccinium padifolium [J]. Food chemistry, 2000. 69: p. 33-36.
    
    112. G. Petri a, U.K.a.A.K., Spectrophotometric and Chromatographic Investigation of Bilberry Anthocyanins for Quantification Purposes[J]. Acta Pharm Hung, 1997. 55: p. 12-13.
    
    113. 方允中,从生命科学到自由基生命科学的求索[J].自由基生命科学进展,1998:p.6.
    
    114.BARRY COMMONER, J.T.G.E.P., Free Radicals in Biological Materials[J]. nature, 1954. 174: p. 689-691.
    
    115.McCord JM, F.I., Superoxide dismutase. An enzymic function for erythrocuprein (hemocuprein).[J]. J Biol Chem, 1969. 244: p. 6049-6055.
    
    116.Mittal, C.K.F. Murad, Activation of guanylate cyclase by superoxide dismutase and hydroxyl radical: a physiological regulator of guanosine 3',5'-monophosphate formation[J]. Proc Natl Acad Sci USA, 1977. 74(10): p. 4360-4.
    
    117.White, A.A., Activation of soluble guanylate cyclase from rat lung by incubation or by hydrogen peroxide[J]. J Biol Chem, 1976. 251(23): p. 7304-12.
    
    118.Ignarro, L.J.P.J. Kadowitz, The pharmacological and physiological role of cyclic GMP in vascular smooth muscle relaxation[J]. Annu Rev Pharmacol Toxicol, 1985. 25: p. 171-91.
    
    119.Radomski, M.W., The anti-aggregating properties of vascular endothelium: interactions between prostacyclin and nitric oxide[J]. Br J Pharmacol, 1987. 92(3): p. 639-46.
    
    120.Roth, S.W. Droge, Regulation of T-cell activation and T-cell growth factor (TCGF) production by hydrogen peroxide[J]. Cell Immunol, 1987. 108(2): p. 417-24.
    
    121.Tyrrell, S.M.K.a.R.M., Heme Oxygenase is the Major 32-kDa Stress Protein Induced in Human Skin Fibroblasts by UVA Radiation, Hydrogen Peroxide, and Sodium Arsenite [J].??Proc Natl Acad Sci USA, 1989. 86:p. 99-103.
    
    122.Storz, G, Transcriptional regulator of oxidative stress-inducible genes: direct activation by oxidation[J]. Science, 1990. 248(4952): p. 189-94.
    
    123.Schreck R, R.P., Baeuerle PA., Reactive oxygen intermediates as apparently widely used messengers in the activation of NF-kB transcription factor and HIV-1[J]. Trends Cell Biol 1991. 1: p. 39-42.
    
    124. 柏华,自由基的研究进展[J].江西饲料,2007.3:p.1-4.
    
    125. 孙中厚,活性氧和活性氮在急性肺损伤中的研究进展[J].国外医学呼吸系统分册, 2004.24:p.52-55.
    
    126. 贾秀月,自由基与抗衰老的研究概况[J].黑龙江医药科学,2007(2):p.75-76.
    
    127.Palmer RM, L-arginine is the physiological precursor for the formation of nitric oxide in endothelium-dependent relaxation.[J]. Biochem Biophys Res Commun. 1988. 153: p. 1251-1256.
    
    128.Stamler, J.S., Biochemistry of nitric oxide and its redox-activated forms[J]. Science, 1992. 258(5090): p. 1898-902.
    
    129.Gow AJ, S.J., Reactions between nitric oxide and haemoglobin under physiological conditions.[J]. nature, 1998. 391: p. 169-173.
    
    130. 童荣生,自由基与心血管疾病[J].现代临床医学,2007.33(2):p.188-191.
    
    131.Melidou, M., Protection against nuclear DNA damage offered by flavonoids in cells exposed to hydrogen peroxide: the role of iron chelation[J]. Free Radic Biol Med, 2005. 39(12): p. 1591-600.
    
    132.Djordjevic, V.B., Free radicals in cell biology[J]. Int Rev Cytol, 2004. 237: p. 57-89.
    
    133.Juranek, I.S. Bezek, Controversy of free radical hypothesis: reactive oxygen species-cause or consequence of tissue injury?[J]. Gen Physiol Biophys, 2005. 24(3): p. 263-78.
    
    134. 李建喜,活性氧自由基在动物机体内的生物学作用[J].动物医学进展,2006(10):p. 33-36.
    
    135.Dhalla, N.S., Role of oxidative stress in cardiovascular diseases[J]. J Hypertens, 2000. 18(6): p. 655-73.
    
    136.Beckman, J.S., Oxidative chemistry of peroxynitrite[J]. Methods Enzymol, 1994. 233: p. 229-40.
    
    137.Adachi, T., S-Glutathiolation by peroxynitrite activates SERCA during arterial relaxation by nitric oxide[J]. Nat Med, 2004. 10(11): p. 1200-7.
    
    138.Yada, T., Hydrogen peroxide, an endogenous endothelium-derived hyperpolarizing factor, plays an important role in coronary autoregulation in vivo[J]. Circulation, 2003. 107(7): p. 1040-5.
    
    139.Papaharalambus, C.A.K.K. Griendling, Basic mechanisms of oxidative stress and reactive oxygen species in cardiovascular injury[J]. Trends Cardiovasc Med, 2007. 17(2): p. 48-54.
    
    140.Patterson, C, Stimulation of a vascular smooth muscle cell NAD(P)H oxidase by thrombin. Evidence that p47(phox) may participate in forming this oxidase in vitro and in vivo[J]. J Biol Chem, 1999. 274(28): p. 19814-22.
    
    141.ten Freyhaus, H., Novel Nox inhibitor VAS2870 attenuates PDGF-dependent smooth muscle cell chemotaxis, but not proliferation[J]. Cardiovasc Res, 2006. 71(2): p. 331-41.
    
    142.Li, J., Hydrogen peroxide induces apoptosis in cerebral vascular smooth muscle cells: possible relation to neurodegenerative diseases and strokes[J]. Brain Res Bull, 2003. 62(2): p. 101-6.
    
    143.Rajagopalan, S., Reactive oxygen species produced by macrophage-derived foam cells regulate the activity of vascular matrix metalloproteinases in vitro. Implications foratherosclerotic plaque stability[J]. J Clin Invest, 1996. 98(11): p. 2572-9.
    
    144. 胡太平,灵芝多糖对Doca高血压大鼠主动脉Nadph氧化酶活性的影响[J].社区医学 杂志,2007(07S):p.1-3.
    
    145. 牟华明,NADPH氧化酶与Rho/Rho-激酶激活在外膜介导的血管重塑中的作用[J]. 中华心血管病杂志,2003(8):p.613-616.
    
    146. 张立春,山葡萄多酚对高血压大鼠NADPH氧化酶活性的影响.[J].中国厂矿医学 2007.20(5):p.462-463.
    
    147. 王智,SOD模拟酶及其生物效果研究进展[J].继续医学教育,2003.17(3):p.36-39.
    
    148. Mugge, A., Release of intact endothelium-derived relaxing factor depends on endothelial superoxide dismutase activity[J]. Am J Physiol, 1991. 260(2 Pt 1): p. C219-25.
    
    149. 马书林,SOD模拟化合物的研究进展[J].药学学报2002.37(3):p.235-240.
    
    150.Park, J.B., Chronic treatment with a superoxide dismutase mimetic prevents vascular remodeling and progression of hypertension in salt-loaded stroke-prone spontaneously hypertensive rats[J]. Am J Hypertens, 2002. 15(1 Pt 1): p. 78-84.
    
    151.Alexander, M.Y., Gene transfer of endothelial nitric oxide synthase but not Cu/Zn superoxide dismutase restores nitric oxide availability in the SHRSP[J]. Cardiovasc Res, 2000. 47(3): p. 609-17.
    
    152.Chu, Y., Gene transfer of extracellular superoxide dismutase reduces arterial pressure in spontaneously hypertensive rats: role of heparin-binding domain[J]. Circ Res, 2003. 92(4): p. 461-8.
    
    153. 方红城,一氧化氮与高血压病的严重程度[J].实用心脑肺血管病杂志,1999.7(14):p. 216-217.
    
    154. 谷胱甘肽过氧化酶类似物Ebselen对脑卒中倾向自发性高血压大鼠的血管内皮与血 管结构的影响[J].中华高血压杂志;,2006.15(4):p.247.
    
    155. 郑建普,黄嘌呤氧化酶对血管内皮功能障碍的影响[J].中华高血压杂志2007.15(1): p.61-65.
    
    156. Zhang, H., Endothelial-specific expression of mitochondrial thioredoxin improves endothelial cell function and reduces atherosclerotic lesions[J]. Am J Pathol, 2007. 170(3): p. 1108-20.
    
    157. 高彦祥,天然色素抗氧化性研究进展[J].食品科学2005(Z1):p.139-144.
    
    158.Bors W, H.W., Michel C, Saran M., Flavonoids as antioxidants: determination of radical-scavenging efficiencies[J]. Methods Enzymol, 1990. 186: p. 343-355.
    
    159.PG, P., Flavonoids as Antioxidants[J]. J nat prod, 2000. 63(7): p. 1035-1042.
    
    160. 徐金瑞,黑大豆种皮花色苷的提取及其抗氧化作用研究[J].农业工程学报,2005. 21(8):p.161-164.
    
    161. 李颖畅,蓝莓花色苷抗氧化活性的研究[J].食品与发酵工业,2007(9):p.61-64.
    
    162.Xu, J.W., Cyanidin-3-glucoside regulates phosphorylation of endothelial nitric oxide synthase[J]. FEBS Lett, 2004. 574(1-3): p. 176-80.
    
    163.Oak, M.H., Delphinidin and cyanidin inhibit PDGF(AB)-induced VEGF release in vascular smooth muscle cells by preventing activation of p38 MAPK and JNK[J]. Br J Pharmacol, 2006. 149(3): p. 283-90.